Table 3 SNPs found to be associated with Estrogen receptor status in breast cancer among BRCA1 and BRCA2 pathogenic variants carriers

BABAM1

19p13.1

rs8170

6844

4483

541

1820

1.12 (0.96–1.29)

0.15

1.23 (1.14–1.33)

2.0 × 10^− 7

iPLEX

[43]

BABAM1

19p13.1

rs67397200

6849

4486

542

1821

1.14 (1.01–1.30)

0.04

1.22 (1.14–1.30)

4.4 × 10^− 9

iPLEX

[43]

CASP8

2q33

rs1045485

60 128

36 976

17 805

5347

0.96 (0.93-1.00)

0.06

0.90 (0.84–0.96)

0.001

Illumina, iPLEX

[46]

LSP1

11p15.5

rs3817198

8628

3996

438

1435

1.07 (0.93–1.22)

0.33

1.07 (1.00-1.15)

0.047

iPLEX, TaqMan

[47]

BRCA2 mutation carriers

FGFR2

10q26.13

rs2981582

4738

2102

841

263

1.35 (1.23–1.48)

1.4 × 10^− 10

1.14 (0.97–1.35)

0.12

iPLEX, TaqMan

[47]

TOX3/

TNRC9

16q12.1

rs3803662

4563

2037

815

255

1.28 (1.16–1.41)

1.5 × 10^− 6

1.06 (0.88–1.29)

0.53

iPLEX, TaqMan

[47]

LSP1

11p15.5

rs3817198

5354

2332

1022

320

1.17 (1.07–1.28)

5.5 × 10^− 4

1.03 (0.81–1.22)

0.70

iPLEX, TaqMan

[47]

SLC4A7/NEK10

3p24.1

rs4973768

5669

2528

1108

329

1.13 (1.04–1.22)

0.0043

1.02 (0.88–1.19)

0.78

iPLEX, TaqMan

[47]